Contineum Therapeutics Inc.
CTNM | NASDAQ
$13.55
$0 (0.00%)
Sep 22, 2026, 1:37 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -9.47 | -6.70 | -5.24 | -5.22 | -1.80 | -3.62 | -8.93 | -16.94 | -21.43 | 15.56 | 13.63 | 17.50 | 13.63 | -31.43 | -51.33 |
PEG Ratio | -3.69 | 0.33 | -0.59 | 0.19 | n/a | -0.34 | -0.22 | -1.19 | -3.54 | 0.03 | -0.17 | -0.15 | -0.01 | 0.86 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.92 | n/a | n/a |
PB Ratio | 2.56 | 1.95 | 1.35 | 1.83 | 0.60 | 0.98 | 1.91 | 2.34 | 2.48 | -5.24 | -5.70 | -6.33 | n/a | 10.09 | 9.86 |
P/FCF Ratio | -11.49 | -8.46 | -6.35 | -6.25 | -2.20 | -4.56 | -11.35 | -14.49 | -16.29 | 24.81 | 20.44 | 14.96 | 12.67 | -42.26 | -94.93 |
P/OCF Ratio | -11.59 | -8.53 | -6.38 | -6.30 | -2.21 | -4.61 | -11.53 | -14.77 | -16.59 | 24.04 | 20 | 14.90 | 12.63 | -42.50 | -94.93 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81.35 | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0 | 0 | -2.55 | -2.84 | -3.17 | n/a | n/a | 0.15 |
Quick Ratio | 37.17 | 38 | 27.50 | 29.07 | 24.51 | 21.47 | 20.69 | 37.06 | 58.92 | 19.20 | 23.29 | 18.50 | n/a | n/a | 6.41 |
Current Ratio | 37.17 | 38 | 27.50 | 29.07 | 24.51 | 21.47 | 20.69 | 37.06 | 58.92 | 19.20 | 23.29 | 18.50 | n/a | n/a | 6.41 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 335.66 | -55.60 | -53.95 |
Return on Equity | -6.32% | -5.78% | -5.81% | -7.09% | -9.36% | -8.65% | -7.35% | -4.88% | -4.14% | 11.13% | 11.44% | 10.22% | n/a | -12.28% | -19.13% |
Return on Assets | -6.05% | -5.53% | -5.48% | -6.70% | -8.77% | -8.06% | -6.84% | -4.75% | -4.07% | -6.81% | -5.96% | -4.50% | n/a | n/a | -14.84% |
Return on Invested Capital | -7.08% | -6.58% | -6.36% | -8.03% | -10.11% | -9.49% | 41.47% | -6.15% | -5.02% | -8.40% | -7.56% | -5.97% | n/a | n/a | -11.32% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 99.92% | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 83.13% | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 84.59% | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 77.87% | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81.29% | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 84.90% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CTNM